{
    "Trade/Device Name(s)": [
        "Dimension Vista\u00ae C1IN Flex\u00ae reagent cartridge",
        "Dimension Vista\u00ae C1IN CAL",
        "Dimension Vista\u00ae C1IN CON"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K072965",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960257",
        "K962410",
        "K962407"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBA",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 21, 2007",
    "Summary Letter Received Date": "October 29, 2007",
    "Submission Date": "October 19, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5250"
    ],
    "Regulation Name(s)": [
        "Complement C1 inhibitor (inactivator) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "C1 Inhibitor"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochemical reaction",
        "Light scatter detection"
    ],
    "Methodologies": [
        "Immunochemical protein quantitation"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista\u00ae C1IN Flex\u00ae reagent cartridge, CAL, and CON for quantitative measurement and control of C1 Inhibitor using immunochemical light scatter on the Dimension Vista\u00ae System.",
    "Indications for Use Summary": "Quantitative measurement of C1 inhibitor in human serum and plasma to aid in diagnosis of hereditary angioneurotic edema and angioedema associated with lymphoma; CAL for method calibration; CON for quality control assessment on the Dimension Vista\u00ae System.",
    "fda_folder": "Immunology"
}